DOCSLIB.ORG

Supplementary Data

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Data SUPPLEMENTARY DATA Supplementary Table 1. Chemokine transcripts modulated in human islets by IL-1β exposure. Fold-Change (IL-1b vs. Gene Symbol p-value (IL-1b vs. Cont.) Cont.) CCL Motif CCL3/CCL3L1/CCL3L3/CCL3P1 0.00264286 33.6703 CCL5 3.28E-05 17.4667 CCL8 0.00275959 10.9838 CCL20 0.00025476 7.44651 CCL7 0.0397251 2.73854 CCL2 0.00474325 2.52303 CCL28 0.0187363 2.41523 CCL4 0.166808 2.33024 CCL22 0.127037 2.18022 CCL11 0.671377 1.17468 CCL16 0.764476 1.06454 CCL26 0.378284 1.02353 CCL27 0.896528 1.00506 CCL1 0.925227 1.00202 CCL14 / CCL15 0.997963 1.00008 CCL25 0.845303 -1.01019 CCL19 0.53194 -1.01633 CCL23 0.374854 -1.0179 CCL24 0.507378 -1.02171 CCL17 0.834009 -1.02651 CCL21 0.297808 -1.0284 CCL13 0.545427 -1.02955 CCL18 0.369049 -1.93245 CX3CL Motif CX3CL1 0.000219617 8.1873 CXCL Motif CXCL3 4.77E-05 12.4706 CXCL5 0.114982 11.9567 CXCL6 0.000991316 8.16419 CXCL10 0.0115036 8.07591 CXCL11 0.0110674 7.04154 CXCL2 0.000953461 5.76661 CXCL1 1.08E-06 5.76188 CXCL7 0.0684859 2.9263 CXCL16 0.325227 1.2783 CXCL9 0.500492 1.26333 CXCL13 0.410061 1.01463 CXCL14 0.837539 1.00591 IL8 (CXCL8) 0.131298 -1.32621 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA CXCL12 0.317907 -1.40545 CXCL17 0.389805 -1.57848 XCL Motif XCL1 0.040432 1.02243 XCL1 / XCL2 0.464888 -1.00954 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA Supplementary Table 2: Chemokine transcripts modulated in human islets by TNFα exposure. p-value (TNFa vs. Gene Symbol Cont.) Fold-Change (TNFa vs. Cont.) CCL Motif CCL5 6.96E-06 21.2476 CCL3/CCL3L1/CCL3L3/CCL3P1 0.0448851 6.92144 CCL20 0.000414905 5.71495 CCL2 0.00717359 2.21738 CCL8 0.308226 1.88492 CCL4 0.498378 1.4471 CCL7 0.745327 1.1438 CCL28 0.761113 1.09821 CCL25 0.635856 1.02293 CCL11 0.96347 1.01604 CCL13 0.865768 1.00746 CCL21 0.858509 1.00432 CCL14 / CCL15 0.983076 1.00065 CCL19 0.924795 -1.00223 CCL27 0.816689 -1.00831 CCL26 0.689016 -1.00963 CCL23 0.591641 -1.0098 CCL1 0.568419 -1.0114 CCL17 0.894878 -1.01526 CCL22 0.943463 -1.03226 CCL24 0.278159 -1.0333 CCL16 0.617253 -1.10091 CCL18 0.715319 -1.27433 CX3CL Motif CX3CL1 0.00961706 3.61172 CXCL Motif CXCL5 0.0710959 14.1789 CXCL11 0.0232147 8.42051 CXCL3 0.00264677 4.22678 CXCL10 0.0466351 4.19985 CXCL6 0.0339153 2.9504 CXCL1 6.99E-05 2.93754 CXCL9 0.0116585 2.48067 CXCL2 0.0132979 2.03215 CXCL16 0.0973236 1.48306 CXCL7 0.67473 1.23758 CXCL13 0.846394 1.0031 CXCL14 0.958412 -1.00138 CXCL17 0.752148 -1.16418 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA CXCL12 0.27451 -1.40974 IL8 (CXCL8) 0.0451573 -1.42879 XCL Motif XCL1 0.775143 1.00261 XCL1 / XCL2 0.3157 -1.01216 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA Supplementary Table 3. Chemokine transcripts modulated in human islets by IFNγ exposure. Fold-Change (IFNg vs. Gene Symbol p-value (IFNg vs. Cont.) Cont.) CCL Motif CCL8 0.0000009074980 283.475 CCL5 0.0000776013000 13.7006 CCL7 0.0132835000000 3.53503 CCL3/CCL3L1/CCL3L3/CCL3P1 0.3375530000000 2.57284 CCL22 0.1474650000000 2.0885 CCL2 0.3187820000000 1.32603 CCL25 0.1147210000000 1.08989 CCL11 0.9100650000000 1.04365 CCL4 0.9603710000000 1.02969 CCL17 0.8339260000000 1.02652 CCL26 0.8034920000000 1.0065 CCL19 0.8757090000000 1.00403 CCL27 0.8702990000000 -1.00636 CCL14 / CCL15 0.6947940000000 -1.01318 CCL21 0.5981750000000 -1.01404 CCL13 0.7785540000000 -1.01479 CCL23 0.4549000000000 -1.01491 CCL1 0.1876210000000 -1.02975 CCL24 0.1759530000000 -1.04613 CCL18 0.9220580000000 -1.07611 CCL16 0.7031190000000 -1.08291 CCL28 0.7538350000000 -1.11094 CCL20 0.5190870000000 -1.30676 CX3CL Motif CX3CL1 0.00001285 16.8165 CXCL Motif CXCL9 0.00000000 2691.41 CXCL10 0.00000011 1672.4 CXCL11 0.00000016 796.145 CXCL12 0.52326600 1.87727 CXCL17 0.37663800 1.59946 CXCL16 0.25804600 1.32851 CXCL3 0.56737100 1.2822 CXCL1 0.39580000 1.19713 CXCL2 0.65746400 1.13011 CXCL13 0.86807200 1.00289 CXCL14 0.58166900 -1.01605 CXCL7 0.96396700 -1.02521 IL8 (CXCL8) 0.02331040 -1.56905 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA CXCL5 0.61560500 -2.12879 CXCL6 0.09139810 -2.47395 XCL Motif XCL1 0.70662500 1.00376 XCL1 / XCL2 0.17658500 -1.01819 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA Supplementary Table 4. Chemokine transcripts modulated in human islets by exposure to cytokine cocktail (Mix: IL1β + TNFα + IFNγ). p-value (Mix vs. Gene Symbol Cont.) Fold-Change (Mix vs. Cont.) CCL Motif CCL8 1.44E-07 760.352 CCL5 9.31E-09 376.663 CCL22 1.02E-06 60.6901 CCL3/CCL3L1/CCL3L3/CCL3P1 0.000855022 59.4942 CCL7 0.000195725 9.56682 CCL20 0.000424883 6.63474 CCL4 0.017054 4.8511 CCL2 0.00106579 3.12556 CCL11 0.051998 2.21085 CCL17 0.0887852 1.25241 CCL28 0.63701 1.17199 CCL14 / CCL15 0.116011 1.0565 CCL13 0.407494 1.04097 CCL24 0.273685 1.03667 CCL27 0.443164 1.03057 CCL19 0.294559 1.02793 CCL26 0.606151 1.01356 CCL1 0.669881 1.00924 CCL23 0.785113 1.00539 CCL25 0.971775 -1.00184 CCL21 0.511491 -1.01758 CCL16 0.567486 -1.12741 CCL18 0.49447 -1.67679 CX3CL Motif CX3CL1 4.00E-06 32.9726 CXCL Motif CXCL9 2.90E-12 3877.66 CXCL10 7.47E-08 2124.52 CXCL11 5.63E-08 1454.11 CXCL3 1.78E-05 16.1993 CXCL5 0.141368 9.97514 CXCL2 0.000508253 6.64056 CXCL1 7.72E-07 6.07301 CXCL6 0.00322939 5.9842 CXCL16 0.029834 1.79618 CXCL12 0.91643 1.10818 CXCL14 0.160439 1.04285 CXCL7 0.954808 1.03172 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA CXCL13 0.442073 1.01362 CXCL17 0.767973 -1.16716 IL8 (CXCL8) 0.147481 -1.30999 XCL Motif XCL1 0.241592 1.01203 XCL1 / XCL2 0.688429 -1.00519 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA Supplementary Table 5. Case descriptions for pancreas samples acquired through the nPOD program. Case Group AutoAb Age (years) Gender Ethnicity C- BMI Clinical History Histopathology HiRes HLA Transplant Cause of (ng/ml) 6036 T1D mIAA+ 49 (34 w/ Female African <0.05 25.5 Diabetes, Ins- islets, plentiful A*6802, 6802 DRB1*07/-, Anoxia diabetes) American multiple and mostly large; B*1401, 1401 DQB1*02/- hospitalizations mixed C*0802, 0802 for ketoacidosis, inflammation most DRB1*0701, pancreatitis, regions with occ. 0701 alcohol use and acinar atrophy DQA1*0301 , drug addict 15 0301, years ago, GI DQB10201, 0201 ulcers 6052 T1D ICA512+ 12 (1 w/ Male African 0.18 20.3 Diabetic Ins+ islets (reduced A*0201, 6801 DRB1*09/16, Cerebral mIAA+ diabetes) American ketoacidosis numbers); Insulitis, B*0602, 1502 DQB1*05/09 edema IA2ic+ (DKA), CMV esp. peri-islet. C*2705, 5001 positive Heterogenous islet DRB1*0901, distribution and 1602 size. DQA1*0102, 0301 DQB1*0303, 0502 ©2011 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db11-0853/-/DC1 SUPPLEMENTARY DATA 6087 T1D mIAA+ 17.5 (4 w/ Male Caucasian <0.05 21.9 Toe amputations, Ins-/Gluc+ islets- A*2601, 3201 DR*4/17 Gun shot ZnT8+ diabetes) colon resection, reduced frequency. B*0801, 4001 wound cataracts, Mild, focal islet C*0304, 0701 glaucoma, infiltrates- some are DRB1*0301, 0404 hypertension, CD3+ while others DQA1*0301 , congestive heart CD3-negative. No 0501, DQB1*0201, failure pancreatitis or 0302 exocrine atrophy. 6112 No Negative 6.3 Female Hispanic 5.11 18.4 Diabetes Normal- excellent A*2601 , 3101 A*26/31, Head diabetes insipidus islet density. No B*5101 , 5801 B*51/58. trauma secondary to inflammation or fatty C*0701 , 1502 DR*4/13, head trauma infiltrates. DRB1*0407 , 1302 DQ*5/7 DQA1*0102 , 0301, DQB1*0301,0501 6115 No Negative 0.4 Male Caucasian 4.59 17.1 Twin, six days in Ins+ normal islets. A*0101, 6801 DR*04/07 Anoxia diabetes ICU, recently Very high Ki67+ B*3501 , 5701 vaccinated for acinar primarily. C*0401 , 0602 rotavirus and No infiltrates. PLN DRB1*0401 , others in blocks. 0701 DQA1*0201 , 0301, DQB1*0301, 0303 6117 No Negative 0.33 Male Caucasian 3.27 18.4 N/A Ins+ islets, normal. A*0101, 1101 A*01/11, Head diabetes High Ki67 in acinar B*1801, 5701 B*18/57, Trauma and moderate in C*0602, 0701 DRB1*07/-, islets. Very mild DRB1*0701 , DQB1*02/09 infiltrates per- 0701 acinar/capsular DQA1*0201 , region. 0201, DQB1*0201, 0303 mIAA: micro insulin autoantibodies ©2011 American Diabetes Association.
Load more

Recommended publications
  • ENSG Gene Encodes Effector TCR Pathway Costimulation Inhibitory/Exhaustion Synapse/Adhesion Chemokines/Receptors
    ENSG Gene Encodes Effector TCR pathway Costimulation Inhibitory/exhaustion Synapse/adhesion Chemokines/receptors ENSG00000111537 IFNG IFNg x ENSG00000109471 IL2 IL-2 x ENSG00000232810 TNF TNFa x ENSG00000271503 CCL5 CCL5 x x ENSG00000139187 KLRG1 Klrg1 x ENSG00000117560 FASLG Fas ligand x ENSG00000121858 TNFSF10 TRAIL x ENSG00000134545 KLRC1 Klrc1 / NKG2A x ENSG00000213809 KLRK1 Klrk1 / NKG2D x ENSG00000188389 PDCD1 PD-1 x x ENSG00000117281 CD160 CD160 x x ENSG00000134460 IL2RA IL-2 receptor x subunit alpha ENSG00000110324 IL10RA IL-10 receptor x subunit alpha ENSG00000115604 IL18R1 IL-18 receptor 1 x ENSG00000115607 IL18RAP IL-18 receptor x accessory protein ENSG00000081985 IL12RB2 IL-12 receptor x beta 2 ENSG00000186810 CXCR3 CXCR3 x x ENSG00000005844 ITGAL CD11a x ENSG00000160255 ITGB2 CD18; Integrin x x beta-2 ENSG00000156886 ITGAD CD11d x ENSG00000140678 ITGAX; CD11c x x Integrin alpha-X ENSG00000115232 ITGA4 CD49d; Integrin x x alpha-4 ENSG00000169896 ITGAM CD11b; Integrin x x alpha-M ENSG00000138378 STAT4 Stat4 x ENSG00000115415 STAT1 Stat1 x ENSG00000170581 STAT2 Stat2 x ENSG00000126561 STAT5a Stat5a x ENSG00000162434 JAK1 Jak1 x ENSG00000100453 GZMB Granzyme B x ENSG00000145649 GZMA Granzyme A x ENSG00000180644 PRF1 Perforin 1 x ENSG00000115523 GNLY Granulysin x ENSG00000100450 GZMH Granzyme H x ENSG00000113088 GZMK Granzyme K x ENSG00000057657 PRDM1 Blimp-1 x ENSG00000073861 TBX21 T-bet x ENSG00000115738 ID2 ID2 x ENSG00000176083 ZNF683 Hobit x ENSG00000137265 IRF4 Interferon x regulatory factor 4 ENSG00000140968 IRF8 Interferon
    [Show full text]
  • Prognostic Value of CXCL17 and CXCR8 Expression in Patients with Colon Cancer
    ONCOLOGY LETTERS 20: 2711-2720, 2020 Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer HONGYAN YAO1,2, YUFENG LV3, XUEFENG BAI4, ZHAOJIN YU4 and XIAOJIAN LIU1 1Department of Pharmacology, School of Basic Medical Sciences, Jinzhou Medical University; 2Nuclear Medicine Department, Jinzhou Central Hospital, Jinzhou, Liaoning 121001; 3Department of Respiration and Critical Care, The Affiliated Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011; 4Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110001, P.R. China Received October 11, 2019; Accepted May 27, 2020 DOI: 10.3892/ol.2020.11819 Abstract. C-X-C motif chemokine ligand 17 (CXCL17) is a CXCL17/CXCR8 signalling may be involved in colon cancer mucous chemokine and its expression is highly correlated with and contribute to improved patient outcomes. that of G protein-coupled receptor 35 (GPR35), which has been confirmed as its receptor and named C‑X‑C motif chemokine Introduction receptor 8 (CXCR8). CXCL17 is upregulated in several types of cancer. However, the biological role of this chemokine Chemokines are a large family of cytokines serving important in colon cancer remains unknown. In the present study, the roles in the immune system, such as the regulation of cell traf- expression levels of CXCL17 and CXCR8 were examined ficking to inflammatory sites (1). By regulating the activity of using immunohistochemistry in 101 colon cancer tissues and cells in homeostasis and signal transduction, chemokines are 79 healthy tumour-adjacent tissues. CXCL17 and CXCR8 involved in numerous physiological and pathological processes expression levels were increased in the colon cancer samples such as angiogenesis, embryonic development, wound healing, compared with tumour-adjacent samples.
    [Show full text]
  • Gene Expression Polarization
    Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression This information is current as of September 27, 2021. Fernando O. Martinez, Siamon Gordon, Massimo Locati and Alberto Mantovani J Immunol 2006; 177:7303-7311; ; doi: 10.4049/jimmunol.177.10.7303 http://www.jimmunol.org/content/177/10/7303 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2006/11/03/177.10.7303.DC1 Material http://www.jimmunol.org/ References This article cites 61 articles, 22 of which you can access for free at: http://www.jimmunol.org/content/177/10/7303.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 27, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 Fernando O.
    [Show full text]
  • Cellular and Plasma Proteomic Determinants of COVID-19 and Non-COVID-19 Pulmonary Diseases Relative to Healthy Aging
    RESOURCE https://doi.org/10.1038/s43587-021-00067-x Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging Laura Arthur1,8, Ekaterina Esaulova 1,8, Denis A. Mogilenko 1, Petr Tsurinov1,2, Samantha Burdess1, Anwesha Laha1, Rachel Presti 3, Brian Goetz4, Mark A. Watson1, Charles W. Goss5, Christina A. Gurnett6, Philip A. Mudd 7, Courtney Beers4, Jane A. O’Halloran3 and Maxim N. Artyomov1 ✉ We examine the cellular and soluble determinants of coronavirus disease 2019 (COVID-19) relative to aging by performing mass cytometry in parallel with clinical blood testing and plasma proteomic profiling of ~4,700 proteins from 71 individuals with pul- monary disease and 148 healthy donors (25–80 years old). Distinct cell populations were associated with age (GZMK+CD8+ T cells and CD25low CD4+ T cells) and with COVID-19 (TBET−EOMES− CD4+ T cells, HLA-DR+CD38+ CD8+ T cells and CD27+CD38+ B cells). A unique population of TBET+EOMES+ CD4+ T cells was associated with individuals with COVID-19 who experienced moderate, rather than severe or lethal, disease. Disease severity correlated with blood creatinine and urea nitrogen levels. Proteomics revealed a major impact of age on the disease-associated plasma signatures and highlighted the divergent contri- bution of hepatocyte and muscle secretomes to COVID-19 plasma proteins. Aging plasma was enriched in matrisome proteins and heart/aorta smooth muscle cell-specific proteins. These findings reveal age-specific and disease-specific changes associ- ated with COVID-19, and potential soluble mediators of the physiological impact of COVID-19.
    [Show full text]
  • Anti-OX40 Antibody Directly Enhances the Function of Tumor-Reactive CD8+ T Cells
    Author Manuscript Published OnlineFirst on August 1, 2019; DOI: 10.1158/1078-0432.CCR-19-1259 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Anti-OX40 antibody directly enhances the function of tumor-reactive CD8+ T cells and synergizes with PI3Kβ inhibition in PTEN loss melanoma Weiyi Peng1,5*, Leila J. Williams1, Chunyu Xu1,5, Brenda Melendez1, Jodi A. McKenzie1,6, Yuan Chen1, Heather Jackson2, Kui S. Voo3, Rina M. Mbofung1,7,, Sara E. Leahey1, Jian Wang4, Greg Lizee1, Hussein A. Tawbi1, Michael A. Davies1, Axel Hoos2, James Smothers2, Roopa Srinivasan2, Elaine Paul2, Niranjan Yanamandra2* and Patrick Hwu1* 1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. 2Oncology R&D, Immuno-Oncology and Combinations RU, GlaxoSmithKline, 1250 S. Collegeville Rd, Collegeville, PA 19426, United States 3Oncology Research for Biologics and Immunotherapy Translation Platform, The University of Texas MD Anderson Cancer Center, Houston, TX. 4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. 5Present address: Department of Biology and Biochemistry, University of Houston, Houston, TX. 6Present address: Eisai Inc., Woodcliff Lake, NJ. 7Present address: Merck Research Laboratories, Palo Alto, CA. Running Title: OX40 agonist-based cancer immunotherapy Keywords: OX40, PI3K, cancer immunotherapy Downloaded from clincancerres.aacrjournals.org on September 25, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 1, 2019; DOI: 10.1158/1078-0432.CCR-19-1259 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 2 *Corresponding Authors: Patrick Hwu, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
    [Show full text]
  • Complementary DNA Microarray Analysis of Chemokines and Their Receptors in Allergic Rhinitis RX Zhang,1 SQ Yu,2 JZ Jiang,3 GJ Liu3
    RX Zhang, et al ORIGINAL ARTICLE Complementary DNA Microarray Analysis of Chemokines and Their Receptors in Allergic Rhinitis RX Zhang,1 SQ Yu,2 JZ Jiang,3 GJ Liu3 1 Department of Otolaryngology, Huadong Hospital, Fudan University, Shanghai, China 2 Department of Otolaryngology , Jinan General Hospital of PLA, Shandong, China 3 Department of Otolaryngology, Changhai Hospital, Second Military Medical University, Shanghai, China ■ Abstract Objective: To analyze the roles of chemokines and their receptors in the pathogenesis of allergic rhinitis by observing the complementary DNA (cDNA) expression of the chemokines and their receptors in the nasal mucosa of patients with and without allergic rhinitis, using gene chips. Methods: The total RNAs were isolated from the nasal mucosa of 20 allergic rhinitis patients and purifi ed to messenger RNAs, and then reversely transcribed to cDNAs and incorporated with samples of fl uorescence-labeled with Cy5-dUPT (rhinitis patient samples) or Cy3- dUTP (control samples of nonallergic nasal mucosa). Thirty-nine cDNAs of chemokines and their receptors were latticed into expression profi le chips, which were hybridized with probes and then scanned with the computer to study gene expression according to the different fl uorescence intensities. Results: The cDNAs of the following chemokines were upregulated: CCL1, CCL2, CCL5, CCL7, CCL8, CCL11, CCL13, CCL14, CCL17, CCL18, CCL19, CCL24, and CX3CL1 in most of the allergic rhinitis sample chips. CCR2, CCR3, CCR4, CCR5, CCR8 and CX3CR1 were the highly expressed receptor genes. Low expression of CXCL4 was found in these tissues. Conclusion: The T helper cell (TH) immune system is not well regulated in allergic rhinitis.
    [Show full text]
  • Cxcl17 and Its Association with T Cells
    Hernández-Ruiz et al., Arch Autoimmune Archives of Autoimmune Diseases Dis 2020; 1(1):28-31. Commentary Cxcl17 and its association with T cells Marcela Hernández-Ruiz1, Albert Zlotnik2* 1Lymphotrek, San Diego, CA, United Keywords: CXCL17, Auto immunities, T cells, IL-23 States Abbreviations: BALF: Bronchoalveolar Lavage Fluid; CLP: Common Lymphoid Progenitor; CNS: 2Department of Physiology Central Nervous System; DP: Double Positive; EAE: Experimental Autoimmune Encephalomyelitis; LN: and Biophysics and Institute for Lymph Nodes; LTHSC: Long-term Hematopoietic Stem Cells; MHC: Major Histocompatibility Complex; Immunology, University of California Irvine, Irvine, CA, United States MOG: Myelin Oligodendrocyte Glycoprotein; STHCS: Short-Term Hematopoietic Stem Cells; TCR: T cell Receptor *Author for correspondence: Email: [email protected] We recently published an article describing the importance of CXCL17 in T cell responses [1]. In summary, we observed the following: Received date: September 02, 2020 Accepted date: September 23, 2020 1) Cxcl17 is necessary to maintain normal ratios of T cell subpopulations in lymph nodes (LN). 2) Cxcl17-/- mice develop more intense inflammatory responses than wild type mice. Copyright: © 2020 Hernández-Ruiz Cxcl17 is a mucosal chemokine predominantly expressed in mucosal tissues of the respiratory M, et al. This is an open-access article tract and digestive system [2-4]. However, it is also expressed in primary immune tissues such as distributed under the terms of the bone marrow and thymus (where its function is currently unknown- Table 1). Microarray data Creative Commons Attribution License, from the Immgen database of 298 purified immune cell subpopulations, and consistent with the which permits unrestricted use, distribution, and reproduction in any analysis shown in table 1, indicates that Cxcl17 is expressed in the thymus.
    [Show full text]
  • Neutrophil Chemoattractant Receptors in Health and Disease: Double-Edged Swords
    Cellular & Molecular Immunology www.nature.com/cmi REVIEW ARTICLE Neutrophil chemoattractant receptors in health and disease: double-edged swords Mieke Metzemaekers1, Mieke Gouwy1 and Paul Proost 1 Neutrophils are frontline cells of the innate immune system. These effector leukocytes are equipped with intriguing antimicrobial machinery and consequently display high cytotoxic potential. Accurate neutrophil recruitment is essential to combat microbes and to restore homeostasis, for inflammation modulation and resolution, wound healing and tissue repair. After fulfilling the appropriate effector functions, however, dampening neutrophil activation and infiltration is crucial to prevent damage to the host. In humans, chemoattractant molecules can be categorized into four biochemical families, i.e., chemotactic lipids, formyl peptides, complement anaphylatoxins and chemokines. They are critically involved in the tight regulation of neutrophil bone marrow storage and egress and in spatial and temporal neutrophil trafficking between organs. Chemoattractants function by activating dedicated heptahelical G protein-coupled receptors (GPCRs). In addition, emerging evidence suggests an important role for atypical chemoattractant receptors (ACKRs) that do not couple to G proteins in fine-tuning neutrophil migratory and functional responses. The expression levels of chemoattractant receptors are dependent on the level of neutrophil maturation and state of activation, with a pivotal modulatory role for the (inflammatory) environment. Here, we provide an overview
    [Show full text]
  • Bioinformatics Identification of CCL8/21 As Potential Prognostic
    Bioscience Reports (2020) 40 BSR20202042 https://doi.org/10.1042/BSR20202042 Research Article Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment 1,* 2,* 3 4 5 1 Bowen Chen , Shuyuan Zhang ,QiuyuLi, Shiting Wu ,HanHe and Jinbo Huang Downloaded from http://portlandpress.com/bioscirep/article-pdf/40/11/BSR20202042/897847/bsr-2020-2042.pdf by guest on 28 September 2021 1Department of Breast Disease, Maoming People’s Hospital, Maoming 525000, China; 2Department of Clinical Laboratory, Maoming People’s Hospital, Maoming 525000, China; 3Department of Emergency, Maoming People’s Hospital, Maoming 525000, China; 4Department of Oncology, Maoming People’s Hospital, Maoming 525000, China; 5Department of Medical Imaging, Maoming People’s Hospital, Maoming 525000, China Correspondence: Shuyuan Zhang ([email protected]) Background: Breast cancer (BC) is the most common malignancy among females world- wide. The tumor microenvironment usually prevents effective lymphocyte activation and infiltration, and suppresses infiltrating effector cells, leading to a failure of the host toreject the tumor. CC chemokines play a significant role in inflammation and infection. Methods: In our study, we analyzed the expression and survival data of CC chemokines in patients with BC using several bioinformatics analyses tools. Results: The mRNA expression of CCL2/3/4/5/7/8/11/17/19/20/22 was remark- ably increased while CCL14/21/23/28 was significantly down-regulated in BC tis- sues compared with normal tissues. Methylation could down-regulate expression of CCL2/5/15/17/19/20/22/23/24/25/26/27 in BC. Low expression of CCL3/4/23 was found to be associated with drug resistance in BC.
    [Show full text]
  • Chemochine E Immunità
    Chemochine e Immunità Mariagrazia Uguccioni AIBT 2016 – Pesaro 1987 – Discovery of the first “chemotactic cytokine” – IL8 Marco Baggiolini Theodor Kocher Institute University of Bern (CH) The Chemokine System - 2016 CCL23 CXCL8 CCL15 CXCL7 CCL14 CXCL6 CCL13 CXCL5 CXCL8 CXCL3 CCL8 CXCL6 CCL7 CXCL11 CXCL2 CXCL1 CCL5 CCL13 CXCL10 CCL3 CCL8 CXCR1 CXCL9 CCL7 CCL26 CXCR2 CCR1 CCL2 CCL13 CXCR3 CCL11 CXCL12 CCR2 CCL8 CCL7 CXCR4 CCL5 CCR3 CXCL13 CXCR5 CCL22 CCL17 CCR4 CXCL16 CXCR6 CCL3 CCR5 CCL4 CXCL17 CXCR8 CCL5 CCL8 CCR6 CX3CR1 CCL20 CX3CL1 XCR1 CCR7 XCL1 CCL19 CCR10 CCR8 XCL2 CCR9 CCL21 CCL27 CCL1 CCL28 CCL25 Cell Migration Selectin-mediated rolling 1 Chemoattractan signalling 2 Integrin-mediated cell adhesion 3 Step 1: attachement and rolling Migration along Step 2: activation chemotactic gradient Step 3: arrest and adhesion Chemokine source Functional Modules in Cell Migration T naive IL-2 CCR7 mature DC Priming B naive IL-6 CXCR5 FDC, TFH Antibody immature DC GM-CSF CCR1, CCR5 T naive Antigen uptake TH1 IFN- CCR5 M Bacteria TH2 IL-4, IL-5 CCR3 Eos/Bas Parasites TH17 IL-17, IL-22 CCR6 Neut Fungi CTL IFN-, Perf CXCR3 M Virus From Blood to Tissue CCR1 Tissue Blood CCR2 CCR2 CCR5 CXCR3 From Tissue to Lymph Nodes CCL21 Lymph nodes are privileged sites normal for dendritic cell-naïve T cell encounters CCL21 CCR7 CCL21 inflamed CCL19 from S. Lira, Nat Immunol 2005, 6:866. Functional Modules in Cell Migration T naive IL-2 CCR7 mature DC Priming B naive IL-6 CXCR5 FDC, TFH Antibody immature DC GM-CSF CCR1, CCR5 T naive Antigen uptake TH1 IFN- CCR5
    [Show full text]
  • The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
    International Journal of Molecular Sciences Review The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature Jan Korbecki 1 , Klaudyna Kojder 2, Patrycja Kapczuk 1, Patrycja Kupnicka 1 , Barbara Gawro ´nska-Szklarz 3 , Izabela Gutowska 4 , Dariusz Chlubek 1 and Irena Baranowska-Bosiacka 1,* 1 Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta´nców Wielkopolskich 72 Av., 70-111 Szczecin, Poland; [email protected] (J.K.); [email protected] (P.K.); [email protected] (P.K.); [email protected] (D.C.) 2 Department of Anaesthesiology and Intensive Care, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-281 Szczecin, Poland; [email protected] 3 Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University in Szczecin, Powsta´nców Wielkopolskich 72 Av., 70-111 Szczecin, Poland; [email protected] 4 Department of Medical Chemistry, Pomeranian Medical University in Szczecin, Powsta´nców Wlkp. 72 Av., 70-111 Szczecin, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-914661515 Abstract: Hypoxia is an integral component of the tumor microenvironment. Either as chronic or cycling hypoxia, it exerts a similar effect on cancer processes by activating hypoxia-inducible factor-1 (HIF-1) and nuclear factor (NF-κB), with cycling hypoxia showing a stronger proinflammatory influ- ence. One of the systems affected by hypoxia is the CXC chemokine system. This paper reviews all available information on hypoxia-induced changes in the expression of all CXC chemokines (CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8 (IL-8), CXCL9, CXCL10, CXCL11, CXCL12 Citation: Korbecki, J.; Kojder, K.; Kapczuk, P.; Kupnicka, P.; (SDF-1), CXCL13, CXCL14, CXCL15, CXCL16, CXCL17) as well as CXC chemokine receptors— Gawro´nska-Szklarz,B.; Gutowska, I.; CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, CXCR7 and CXCR8.
    [Show full text]
  • Follicular Thyroid Carcinoma but Not Adenoma Recruits Tumor-Associated
    Huang et al. BMC Cancer (2016) 16:98 DOI 10.1186/s12885-016-2114-7 RESEARCH ARTICLE Open Access Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15 Feng-Jiao Huang1†, Xiao-Yi Zhou1†, Lei Ye1*, Xiao-Chun Fei2, Shu Wang1,3, Weiqing Wang1 and Guang Ning1,3 Abstract Background: The differential diagnosis of follicular thyroid carcinoma (FTC) and follicular adenoma (FA) before surgery is a clinical challenge. Many efforts have been made but most focusing on tumor cells, while the roles of tumor associated macrophages (TAMs) remained unclear in FTC. Here we analyzed the differences between TAMs in FTC and those in FA. Methods: We first analyzed the density of TAMs by CD68 immunostaining in 59 histologically confirmed FTCs and 47 FAs. Cytokines produced by FTC and FA were profiled using antibody array, and validated by quantitative PCR. Chemotaxis of monocyte THP-1 was induced by condition medium of FTC cell lines (FTC133 and WRO82-1) with and without anti-CCL15 neutralizing antibody. Finally, we analyzed CCL15 protein level in FTC and FA by immunohistochemistry. Results: The average density of CD68+ cells was 9.5 ± 5.4/field in FTC, significantly higher than that in FA (4.9 ± 3.4/field, p < 0.001). Subsequently profiling showed that CCL15 was the most abundant chemokine in FTC compared with FA. CCL15 mRNA in FTC was 51.4-folds of that in FA. CM of FTC cell lines induced THP-1 cell chemotaxis by 33 ~ 77 %, and anti-CCL15 neutralizing antibody reduced THP-1 cell migration in a dose-dependent manner.
    [Show full text]